This site is intended for healthcare professionals only
LoginRegister
Novartis AG to Exit India Arm in Rs 1,446 Cr Deal, ChrysCapital-Led Consortium Buys 70.68% StakeCDSCO Panel Approves Novartis' Protocol Amendment proposal for Iptacopan Clinical study in Kidney...
Dr Reddys Labs reappoints G V Prasad as Co-Chairman, MDDr Reddy's Labs reappoints G V Prasad as Co-Chairman, MD
Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 croreTPG to acquire 35% stake in SCHOTT Poonawalla from SII
Sun Pharma unit Taro recalls over 17k units of antifungal medication in USFDC recalls more than 60000 bottles of glaucoma medication in US
Dr Reddys Labs Switzerland incorporates new wholly-owned arm in VietnamDr Reddy's Labs Switzerland incorporates new wholly-owned arm in Vietnam
CDSCO Cancels Kult Apps Cosmetic Import Registrations Over False LabelingPost-Patent Expiry Boom, Empagliflozin Sees Brand Flood, 147 Brands Launched: Pharmatrac
NPPA Fixes Retail Rates for 36 Key Drugs Like Atorvastatin, Dapagliflozin, GemcitabineNPPA fixes retail prices for Otsuka Pharmaceutical's 3 formulations
CDSCO to Reject Long-Pending SUGAM Applications After 30 Days for Non-Response to QueriesCDSCO issues Revised Export NOC Guidance document for Manufacture of Unapproved, Approved New Drugs
Rick Suarez Named Head of AstraZenecas US Biopharma Business Amid USD 50 Billion Expansion PlanAstraZeneca Pharma India gets CDSCO approval for Enhertu for new breast cancer indication
Biocon Secures USFDA Nod for Generic Liraglutide Prefilled Pens for DiabetesBiocon posts more than twofold increase in Q4 profit
Senores Pharma to acquire two products of USFDA approved ANDAs from Teva Pharma USASenores Pharma buys USFDA approved Tramadol Tablets from APDM Pharma
ZydusZydus Lifesciences bags USFDA nod for Glatiramer Acetate Injection for relapsing forms of Multiple...
X